Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedApr 20, 2025
DataAggregated Company Financials
Companies9
- 7D0.2%
- 3M14.7%
- 1Y-22.2%
- YTDn/a
In the last week, Drug Retail has been flat. As for the longer term, the industry has declined 22% in the last year. Earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 20 Apr 2025 | CN¥92.5b | CN¥121.0b | CN¥3.9b | 22.7x | 23.8x | 0.8x |
| Tue, 18 Mar 2025 | CN¥89.3b | CN¥121.0b | CN¥3.9b | 20.1x | 22.9x | 0.7x |
| Thu, 13 Feb 2025 | CN¥83.9b | CN¥121.0b | CN¥3.9b | 19.1x | 21.5x | 0.7x |
| Sat, 11 Jan 2025 | CN¥80.8b | CN¥121.0b | CN¥3.9b | 19x | 20.7x | 0.7x |
| Mon, 09 Dec 2024 | CN¥89.7b | CN¥121.0b | CN¥3.9b | 19.9x | 23x | 0.7x |
| Wed, 06 Nov 2024 | CN¥94.4b | CN¥121.0b | CN¥3.9b | 21.3x | 24.2x | 0.8x |
| Fri, 04 Oct 2024 | CN¥90.4b | CN¥119.6b | CN¥4.3b | 20.6x | 20.9x | 0.8x |
| Sun, 01 Sep 2024 | CN¥72.5b | CN¥119.0b | CN¥4.5b | 22.1x | 16x | 0.6x |
| Tue, 30 Jul 2024 | CN¥73.7b | CN¥118.4b | CN¥4.8b | 16.5x | 15.4x | 0.6x |
| Thu, 27 Jun 2024 | CN¥86.5b | CN¥118.4b | CN¥4.8b | 21.8x | 18x | 0.7x |
| Sat, 25 May 2024 | CN¥124.5b | CN¥118.4b | CN¥4.8b | 25.5x | 26x | 1.1x |
| Mon, 22 Apr 2024 | CN¥119.1b | CN¥114.8b | CN¥5.2b | 22.3x | 22.9x | 1x |
| Wed, 20 Mar 2024 | CN¥115.2b | CN¥115.1b | CN¥5.3b | 20.1x | 21.9x | 1x |
| Fri, 16 Feb 2024 | CN¥122.1b | CN¥115.9b | CN¥5.8b | 20.5x | 21x | 1.1x |
| Sun, 14 Jan 2024 | CN¥126.2b | CN¥116.0b | CN¥5.7b | 22x | 22x | 1.1x |
| Tue, 12 Dec 2023 | CN¥126.4b | CN¥116.0b | CN¥5.7b | 22.6x | 22x | 1.1x |
| Thu, 09 Nov 2023 | CN¥121.4b | CN¥115.4b | CN¥5.7b | 21.8x | 21.4x | 1.1x |
| Sat, 07 Oct 2023 | CN¥120.4b | CN¥113.6b | CN¥5.7b | 23.1x | 21.2x | 1.1x |
| Mon, 04 Sep 2023 | CN¥122.2b | CN¥113.2b | CN¥5.7b | 24.2x | 21.5x | 1.1x |
| Wed, 02 Aug 2023 | CN¥129.4b | CN¥109.7b | CN¥5.4b | 27.7x | 23.8x | 1.2x |
| Fri, 30 Jun 2023 | CN¥131.3b | CN¥109.7b | CN¥5.4b | 27.8x | 24.1x | 1.2x |
| Sun, 28 May 2023 | CN¥133.3b | CN¥109.7b | CN¥5.4b | 27.7x | 24.5x | 1.2x |
| Tue, 25 Apr 2023 | CN¥134.3b | CN¥96.2b | CN¥4.5b | 36.1x | 29.7x | 1.4x |
| Thu, 23 Mar 2023 | CN¥139.7b | CN¥91.6b | CN¥4.2b | 34.2x | 33.3x | 1.5x |
| Sat, 18 Feb 2023 | CN¥148.7b | CN¥90.3b | CN¥4.0b | 36.6x | 37x | 1.6x |
| Mon, 16 Jan 2023 | CN¥150.6b | CN¥90.3b | CN¥4.0b | 38.4x | 37.4x | 1.7x |
| Wed, 14 Dec 2022 | CN¥155.6b | CN¥90.3b | CN¥4.0b | 39.8x | 38.7x | 1.7x |
| Fri, 11 Nov 2022 | CN¥138.2b | CN¥90.3b | CN¥4.0b | 34.1x | 34.3x | 1.5x |
| Sun, 09 Oct 2022 | CN¥113.2b | CN¥85.6b | CN¥3.8b | 35.1x | 29.6x | 1.3x |
| Tue, 06 Sep 2022 | CN¥118.9b | CN¥84.2b | CN¥3.8b | 37.1x | 31.4x | 1.4x |
| Thu, 04 Aug 2022 | CN¥118.3b | CN¥80.8b | CN¥3.7b | 38.3x | 31.7x | 1.5x |
| Sat, 02 Jul 2022 | CN¥116.3b | CN¥80.8b | CN¥3.7b | 37.8x | 31.2x | 1.4x |
| Mon, 30 May 2022 | CN¥106.4b | CN¥80.8b | CN¥3.7b | 33.9x | 28.5x | 1.3x |
| Wed, 27 Apr 2022 | CN¥81.6b | CN¥75.7b | CN¥4.0b | 22.9x | 20.2x | 1.1x |
Price to Earnings Ratio
20.2x
Current Industry PE
- Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 25.3x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.76x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | 0.22% | |
| Consumer Staples | -0.091% | |
| Food and Staples Retail | 0.032% | |
| Drug Retail | 0.22% | |
| Big Box Super Stores | 1.78% | |
| Food Distributors | -0.15% | |
| Food Retail | -0.37% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 002727 Yixintang Pharmaceutical Group | CN¥12.92 | 1.8% +CN¥134.7m | -37.0% | PE48.5x | |
| 603939 Yifeng Pharmacy Chain | CN¥28.38 | 0.2% +CN¥60.6m | -20.2% | PE22.6x | |
| 301017 ShuYu Civilian Pharmacy | CN¥10.67 | 1.0% +CN¥44.3m | -9.8% | PS0.4x | |
| 301408 Anhui Huaren Health Pharmaceutical | CN¥11.05 | 0.9% +CN¥40.0m | 2.6% | PE32.8x | |
| 300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | CN¥24.40 | 1.2% +CN¥27.7m | 9.4% | PE142.7x |